As COVID-19 persists in our communities, Cytotheryx remains committed to developing a consistent, high-quality source of human hepatocytes, and we will continue to work together through this unprecedented and ever-changing time in our country. Therefore, we want to address a few questions or concerns that might arise:
We remain committed to delivering value to our investors and partners, especially during this time when it is important to be good corporate citizens, protect our team and continue our vital work.
We are taking precautions in order to halt the spread of the virus in our community. We have implemented protocols to ensure all members of our team are safe while in the office, and we will continue to monitor the situation as new data becomes available.
If you have any questions about these guidelines, please email firstname.lastname@example.org.
We are dedicated to our goals and will transparently share updates during this time of concern and beyond. Please check back for updates to this information as the situation changes.